Companies › CTOR

CITIUS ONCOLOGY INC COM (CTOR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001851484 · EDGAR filings · Updated 2026-06-05

CITIUS ONCOLOGY INC COM (CTOR) has reported institutional ownership of 15.3%, with 14 institutional managers holding positions valued at $8.83M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-06-05 — EFFECT filed
• 2026-06-04 — SCHEDULE 13D/A filed
• 2026-06-01 — Prospectus supplement (424B3) filed
• 2026-06-01 — Current report (8-K) filed
• 2026-05-29 — DEF 14C filed
• 2026-05-29 — Shelf registration (S-3) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CITIUS ONCOLOGY INC COM has 14 institutional holders and institutional ownership of 15.3%.

Insider activity

Insiders reported 32 transactions (0 buys, 0 sells) across 10 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Boundless Bio Inc (BOLD) · CYTOSORBENTS CORP (CTSO) · ONEMEDNET CORP (ONMD) · Entera Bio Ltd (ENTX) · IMMUCELL CORP (ICCC) · METAGENOMI THERAPEUTICS INC (MGX)